Metabonomic analysis was performed by the Agilent 1,290 Infinity Ⅱ UHPLC system coupled to an Agilent 6545 UHD and Accurate-Mass Q-TOF/MS. Mobile phase: A: aqueous solution. B: acetonitrile solution. Flow rate: 0.35 ml/min. Column temperature: 25°C. Injection volume: 2 μL. Gradient elution condition optimized: 0–2 min, 1% B; 2–7 min, 1–15% B; 7–9 min, 15–50% B; 9–13 min, 50–95% B; 13–15 min, 95% B. Post time was set as 5 min. Mass spectrometry was operated in both positive and negative ion modes. Differential metabolites were further identified by MS/MS with collision energy of 10 v, 20 v, and 40 v. Raw data were converted by the self-contained software of the Agilent system. Then the peak was identified by the XCMS program in the R software platform. The peel data were subjected to internal standard normalization and weight normalization and the flesh data were subjected to internal standard normalization. Visualization matrices containing sample name, m/z-RT pair, and peak area were obtained. For the peel simples, 1,428 features were obtained in the positive mode. After editing, the data matrices were imported into SIMCA-P 13.0 After preprocessing, the data were analyzed by Orthogonal Partial Least Square Discriminate Analysis (OPLS-DA).

The metabolites were qualitatively analyzed by searching the self-built standard substance database according to the results of the secondary spectrum and then the METLIN, HMDB, HMDB-SERUM, KEGG, CHEBI, LIPID, and other public databases were searched to provide alternative substances. In our study, the Variable Importance in Projection (VIP, threshold >1) of the first principal component of the OPLS-DA model and the p value (threshold <0.05) of Student’s t-test were used to find differentially expressed metabolites.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.